*In most patients, one LACRISERT® placed into each eye, once daily, is usually effective in providing all-day symptom relief.

Some patients may require twice daily use for optimal results.

 
 

The LACRISERT® insert softens within 1 hour and dissolves in 14 to 18 hours.†

†Based on pre-clinical data.

Patient Candidates

Your moderate to severe dry eye patients may benefit from LACRISERT® if they:

  • Remain symptomatic in spite of frequent use of artificial tears
  • Are unwilling to frequently apply artificial tears or use ointments or gels
  • Want to continue wearing contact lenses
  • Have undergone LASIK or cataract surgery
  • Suffer from dry eye symptoms secondary to Sjögren’s syndrome
Find Out More
Experts Chose LACRISERT®

Our featured eye doctors discuss topics like moderate to severe dry eye prevalence in their practices, why they choose LACRISERT®, and what patient types may benefit from treatment.

Paul Karpecki, OD

Koffler Vision Group

Doug Devries, OD

Eyecare Associates of Nevada

Jack Schaeffer, OD

Schaeffer Eye Center

Case Studies

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
  • Instructions for inserting and removing LACRISERT® should be carefully followed.
  • If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery.
  • The following adverse reactions have been reported, but were in most instances mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

To report suspected adverse reactions, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or FDA.gov/medwatch.

Click here for full Prescribing Information

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
  • Instructions for inserting and removing LACRISERT® should be carefully followed.

Important Safety Information

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.